NCT00060476 2017-05-09
Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
4 trialsNCT00031863 2013-08-02
Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00165048 2005-12-09
Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial
Chinese University of Hong Kong
Phase 3 Unknown
NCT00164892 2005-11-17
Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
Chinese University of Hong Kong
Phase 3 Unknown